16S rRNA sequencing for fermented food research
16s rrna sequencing for fermented food research compared: V3-V4 amplicon wins for routine batches, full-length 16S for species calls. 2026 buying guide.
YAContent TeamRead more
All articles

Metagenome sequencing for soil microbiome studies
Metagenome sequencing for soil microbiome studies in 2026: shotgun vs amplicon vs hybrid assembly, extraction pitfalls, and which approach to buy or skip.
YAContent TeamAug 1, 2026
18S rRNA sequencing for fungal contamination studies
18S rRNA sequencing for fungal contamination in 2026: which method to buy, when Sanger confirmation beats amplicon panels, and what to skip in pharma QC.
YAContent TeamAug 1, 2026
Microbial identification for food safety audits
Compare WGS, Sanger, MALDI-TOF and culture methods for microbial identification for food safety audits in 2026 — verdicts, turnaround, and audit-readiness.
YAContent TeamAug 1, 2026
16S rRNA sequencing for gut health research
16s rrna sequencing for gut health research compared for 2026: V3-V4 amplicon wins for cohort studies, full-length 16S for strain resolution. See the verdict.
YAContent TeamAug 1, 2026
Sanger sequencing for mutation confirmation in clinical samples
Sanger sequencing for mutation confirmation runs at 99.9% base accuracy — see which NGS and exome workflows need it before a clinical report ships in 2026.
YAContent TeamJul 31, 2026
Whole genome sequencing for plant breeding programs
Whole genome sequencing for plant breeding programs compared: short-read, long-read, hybrid, and GBS strategies with 2026 coverage, cost, and verdicts.
YAContent TeamJul 31, 2026
Sanger sequencing for plasmid confirmation
Sanger sequencing for plasmid confirmation in 2026: primer strategy, read coverage, and when NGS-based QC beats a single read, with clear Buy/Consider verdicts.
YAContent TeamJul 31, 2026
Microbial identification for pharmaceutical quality control
Compare Sanger sequencing, WGS, MALDI-TOF and biochemical kits for microbial identification for pharmaceutical quality control -- 2026 verdicts and use cases.
YAContent TeamJul 31, 2026
Whole genome sequencing for bacterial outbreak investigation
Whole genome sequencing for bacterial outbreak investigation compared for 2026 — short-read, hybrid, and nanopore approaches with clear Buy/Skip verdicts.
YAContent TeamJul 31, 2026
NGS panel testing for hereditary cancer screening
Compare NGS panel options for hereditary cancer screening in 2026 — gene counts, turnaround times, VUS risk, and clear Buy/Consider/Skip verdicts for each.
YAContent TeamJul 30, 2026
NGS for cancer biomarker discovery
NGS for cancer biomarker discovery in 2026: compare targeted panels, WES, WGS, RNA-seq and ctDNA liquid biopsy with clear buy/consider/skip verdicts.
YAContent TeamJul 30, 2026
Whole exome sequencing for rare disease diagnosis
Whole exome sequencing for rare disease diagnosis: compare trio vs singleton WES, coverage depth, and reporting standards before choosing a lab in 2026.
YAContent TeamJul 30, 2026